Most Recent
Air-conditioning giant Seeley is appealing a decision by IP Australia shooting down its bid to block a father-son team from registering their ‘Natural Cool Air’ trade mark.
An IP Australia delegate has rejected German drug maker Ever Neuro Pharma's claim that extensive experimental evidence was needed to prove the usefulness of a Parkinson's drug developed by UK-based Britannia Pharmaceuticals.
A judge has found that Uniden infringed rival GME’s design patent for a handheld radio, derailing the company's plan for an Australian launch of two products.
The Full Federal Court has rejected German drug maker Boehringer Ingelheim's appeal of ruling that shot down its opposition to Merck Sharp & Dohme's patent application for an injectable anti-parasite drug for livestock.
The High Court has granted special leave to a cosmetic company to challenge a judgment finding it infringed Botox maker Allergan's trade marks by marketing its topical creams as Botox alternatives.
The High Court has been asked to wade into the debate over whether artificial intelligence can be named as an inventor on patent applications, after the Full Court overturned a landmark victory for AI pioneer Dr Stephen Thaler.
Cotton On has settled court proceedings brought against rival surf and streetwear label Ghanda for threatening it with a copyright and trade mark infringement lawsuit.
Two of the world's largest manufacturers of explosives have taken their fight over three patents for a detonation device to the Federal Court.
The High Court has rejected plumbing company Repipe's application to hear its case centred on the question of patent eligibility for computer-implemented inventions, saying the case was not an appropriate vehicle for special leave.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.